BelloXOS

BelloXOS

BelloXO is an acellular product developed from  exosome rich conditioned media  harvested  from Mesenchymal  Stem Cells (MSCs) derived from Umbilical Cord Allograft Tissue. It is packaged aseptically in serum vials and is intended for a single patient, one time use.

Description

Disclaimer: This product is NOT available in North America. 

 

Overview:

 

BelloXOS is an acellular flowable product developed from exosome rich conditioned media harvested from Mesenchymal Stem Cells (MSCs) derived from Umbilical Cord Allograft Tissue. It is packaged aseptically in serum vials and the product is available in either 1cc, 2cc or 5cc vials.

 

BelloXOS™ is intended for topical, injection or intravenous use as determined by a healthcare provider. The product is restricted to use by a licensed healthcare provider.

 

Each vial contains billions of exosomes as determined by surface marker characterization. Bello Bio uses a proprietary process to produce the exosome rich supernatant, then separates the exosomes for the most concentrated product available.

Screening/Testing: Bello Bio complies with screening and testing standards consistent with the American Association of Tissue Banks, cGMP standards, and the highest level of any regulatory agency globally. This includes a donor screening questionnaire, donor labwork, medical director review and extensive tissue testing.

 

Only if ALL donor tissue testing results are completely negative (from many vials) does the biologics pass quality control standards. Industry standard cryopreservation techniques are incorporated to ensure the highest viability of the mesenchymal stem cells.

Sizes Available:

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “BelloXOS”

Your email address will not be published. Required fields are marked *

FAQ

GMP stands for Good Manufacturing Practice, which is a set of regulations, rules, and guidelines published by all healthcare authorities. Examples of these healthcare authorities include:

  • US Food and Drug Administration (FDA)
  • World Health Organization (WHO)
  • European Union (in the EUDRALEX)
  • UK Medicines & Healthcare Regulatory Agency (MHRA)
  • Drug Regulatory Authority of Pakistan (DRAP)

 

GMP regulations provide us with a system that should ensure consistent, controlled products and services. Good implementation of the regulation requirements and guidelines helps us provide the best and safest services and products. These GMP guidelines include all aspects of the product’s life cycle and manufacturing process, from product development and raw materials selection to the final production process, testing, storage, and shipment.

The “c” stands for “current” as a reminder that systems, processes and technologies must be kept up to date to comply with the latest regulations. "

It is important to understand that the FDA does not “approve” or certify health care facilities, laboratories, or manufacturers as GMP. The FDA inspects product manufacturers to verify that they comply with good manufacturing practices but does not issue GMP certificates. 

Birth tissue refers to the “products of conception” that are typically discarded as medical waste after a birth. This may include the placenta, amniotic fluid, umbilical cord tissue and umbilical cord blood.

Of note, Bello Bio USA obtains birth tissue from an accredited tissue recovery agency in the USA. This agency screens consenting donors rigorously to make sure they are acceptable with the lowest risk factors possible.

Bello Bio Pakistan maintains its own birth tissue recovery program. As Bello Bio is located within Pak-American Hospital (PAH), mothers undergoing scheduled c-sections at the hospital may consent to donate their birth tissue.

Bello Bio performs rigorous donor screening both on the mother as well as the tissue itself. The tissue testing is consistent with the regulations put forth by the FDA and recommended by AATB.

The United States FDA has put forth the term Minimal Manipulation referring to tissue products where the processing of the HCT/P does not alter the original relevant characteristics of the tissue relating to the tissue's utility for reconstruction, repair, or replacement.

HCT/P refers to human cells, tissues, and cellular and tissue-based products. Here is how the FDA regulations read (word for word).

The FDA defines minimal manipulation as:

  • For structural tissue, processing that does not alter the original relevant characteristics of the tissue relating to the tissue’s utility for reconstruction, repair, or replacement;
  • For cells or nonstructural tissues, processing that does not alter the relevant biological characteristics of cells or tissues.

ISO certification is a credential that validates a business's fulfillment of requirements relating to quality process standards as defined by the International Standards Organization (ISO). The ISO is a non-governmental organization that determines specifications for products, services and systems for quality and efficiency.

Because it’s an International requirement, it’s one way for businesses to comply with regulations that are deemed acceptable around the world. In fact, ISO has standards in over 150 countries for all types of agriculture, food safety, health care, manufacturing, risk management, technology and occupational health/safety.

Bello Bio achieved ISO Certification in both USA and Pakistan as a Cleanroom meeting ISO 7 Standards for acceptable particle counts.

Obtained from third parties, ISO certifications function as proof that a business abides by the standards set forth by the ISO. As such, they help to instill confidence in clients and other interested parties that the business conducts itself efficiently and strives for high quality.

The products manufactured at Bello Bio USA or Pakistan are only available for purchase by licensed healthcare professionals. Bello Bio places a current license on file for each customer.

Bello Bio employs several molecular biologists. These individuals are key to the successful production of the clinical and research biologics in both the USA and Pakistan. In order to become a molecular biologist, individuals must study for several years at an institution of higher learning. Once they complete all of the rigorous course load to master the technology necessary for working in the field, they must put forth a strong dissertation and successfully defend it to a faculty committee.

The process of obtaining a PhD as a Molecular Biologist generally takes 4 to 6 years. Drs. Khan and Minter-Dykhouse both obtained their PhD from highly respectable institutions, are well published and have devoted their lives to producing and researching first rate cellular therapy products.

Molecular biologists play a vital role in advancing our understanding of genetics, cell biology, and biochemistry. Their research is used in a variety of fields, including medicine, agriculture, biotechnology, and environmental science. Molecular biologists may work in academic settings, government agencies, or private industry, where they conduct research, develop new technologies, and analyze data to solve complex biological problems.

“Bello” is an Italian word meaning beautiful. “Bio” is short for biologics which means the study of life. Together, Bello Bio means the Beautiful Study of Life!

Get Early Access

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. 

Copyright © 2023 . Bello Bio . All Right Reserved.

Disclaimer: For Medical Professionals Only